Evaluation of Neuromuscular ElectroStimulation in Addition to a Physical Activity Program

Inclusion Criteria:

• Patient treated with pharmacological androgen deprivation therapy for prostatecancer for more than 26 weeks;

• Performance index (WHO): 0 or 1;

• Patient able to understand the information related to the study, to read theinformation leaflet and having consented to participate in the study;

• Patient benefiting from a social security scheme;

Exclusion Criteria:

• Weight ≥ 130 kg;

• Vegetarian food;

• Other associated neoplasia;

• Patient having undergone a bilateral orchiectomy;

• Painful bone metastases, or at risk of fracture;

• Anemia (hemoglobin < 10 g/dL);

• Thrombocytopenia (platelets < 50 G/L);

• Renal impairment (creatinine clearance < 60 mL/min, or albuminuria > 30);

• Patient planning to travel more than 4 weeks continuously in the next 52 weeks;

• Absolute contraindication to physical training (e.g. musculoskeletal, cardiovascularor neurological disorders), according to the doctor specializing in the associatedmedical condition;

• Contraindication to the use of the neuromuscular electrostimulation device or theimpedance meter, in particular infectious disease in the acute phase, fungalinfection, dermatitis, unbalanced arrhythmia, epilepsy, wearing an activeimplantable device (pacemaker, heart artificial, prosthesis incorporating anelectromagnetic system), open wound;

• Sports activity already supervised by a third party or at an equal or higher levelthan the bodybuilding/muscle strengthening work recommended in the study;

• Protected adult patient (under guardianship or curatorship, or under a regime ofdeprivation of liberty);

• Patient participating in another research, or in a period of exclusion from anotherresearch.